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ABSTRACT 
Myocardial infarction with normal coronary angiography (MINCA) is an important subgroup of 
myocardial infarction for which the prevalence, underlying pathophysiology, prognosis and 
optimal management are still largely unknown. Interest in and awareness of MINCA has 
increased in recent years due to the frequent use of coronary angiography, the description of 
Takotsubo stress cardiomyopathy (TSC) and new sensitive troponin assays. The purpose of this 
thesis was to investigate the prevalence and clinical characteristics of MINCA using 
cardiovascular magnetic resonance (CMR) and particularly to investigate the effect of stress on 
TSC using Doppler tissue imaging (DTI), heart rate variability (HRV), salivary cortisol (SC) 
and non-invasive coronary flow reserve (CFR). 
In Study I, 176 patients with MINCA were screened at five coronary care units in the 
Stockholm Metropolitan Area. 152 of them were investigated using CMR which showed 67% 
of the patients as being normal, 19% having signs of myocardial necrosis and 7% the diagnosis 
was myocarditis in of the patients. The remaining patients were either diagnosed with 
hypertrophic cardiomyopathy or were undecided. Twenty-two percent of all MINCA with a 
normal CMR fulfilled the Mayo Clinic criteria for TSC. 
In Study II, we tested the hypothesis that compared to sex- and age-matched controls TSC 
patients have an increased vulnerability to stress even after the acute event. Using dobutamine 
stress echocardiography (DSE) and DTI we investigated the TSC patients approximately 20 
months (619 ± 297 days) after the acute event. At rest left ventricular myocardial performance 
index (LV-MPI) was significantly higher for TSC patients (p=0.01). During stress, however, 
there were no significant differences between the groups. 
Study III was in many ways similar to Study II except that mental stress was used instead of 
dobutamine stress. The study was performed 28 months after the acute event. In addition to 
DTI, HRV and SC were also studied. During mental stress there were no significant differences 
between TSC patients and sex- and age-matched controls for DTI, HRV and SC. There was a 
trend towards less increase in SC after stress in TSC patients compared to controls. A self-
estimated acute stress scale (Likert-type scale from 0–6) was 2.8 and 2.6 during mental stress 
for TSC patients and controls, respectively. During the acute event TSC patients retrospectively 
estimated their acute stress level at 4.4. In Study IV, dobutamine stress was used to investigate 
the effect of stress on non-invasive CFR. At low-dose dobutamine, CFR was significantly lower 
in TSC patients compared to controls (p=0.017). There were no differences in CFR at high-dose 
dobutamine between the groups. 
Conclusion: MINCA is more common than previously thought and is associated with a normal 
CMR. TSC constitutes a substantial part of MINCA. Studies II and III point to a slow recovery 
for TSC patients measured by DTI but no sign of vulnerability was revealed by dobutamine or 
mental stress measured by DTI, HRV or SC. We could not confirm that the catecholamine 
dobutamine induced microvascular dysfunction in TSC patients. However, we found a small but 
significant difference in CFR at low-dose dobutamine, which implies that the role of 
microvascular function in TSC needs to be further explored.  
 
Key words: Takotsubo stress cardiomyopathy, cardiovascular magnetic resonance, dobutamine 
stress echocardiography, mental stress, coronary flow reserve 
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INTRODUCTION 
 
In the last two decades the amount of acute or sub-acute coronary angiographies performed has 
increased dramatically 
1
. Almost all large or medium-size hospitals in Sweden today have the 
ability to perform coronary angiography in an acute or sub-acute manner. One factor driving the 
increased use of acute or sub-acute coronary angiography is the existence of ever more sensitive 
cardiac enzymes. Recently high-sensitive troponins have come into clinical use 
2
. Troponins 
have the ability to record even the most minutely affected myocardium although there are still 
only limited amounts of data with regards to high-sensitive troponins 
3
. Accordingly, the 
amount of patients in whom the cause of chest-pain or elevated troponins is unclear has 
increased. The increasing number of patients without a proper diagnosis puts clinicians in a 
diagnostic dilemma. What are the reasons for elevated troponins in the patients when the 
underlying cause cannot be found on coronary angiography? What else can be done to increase 
the number of patients with a proper diagnosis? 
 
 
MYOCARDIAL INFARCTION WITH NORMAL CORONARY ANGIOGRAPHY  
During the first decades of the 20
th
 century there were observations of acute myocardial 
infarction without obstructive coronary disease. In those days the diagnosis was made during 
necropsy 
4-6
. Since the introduction of coronary angiography in the 1960s clinicians have 
observed an increasing number of cases of myocardial infarction with normal coronary 
angiography (MINCA) 
7 8
. In the 1970s several cardiac enzymes began to be measured and an 
even more exact diagnosis was possible. Already by the early 1970s an estimate was done that 
of all cases of acute myocardial infarction MINCA constituted around 4% 
9
. The origins of 
these cases were thought to be mainly spontaneous reperfusion of a previously occluded artery 
but also misinterpretation of the coronary angiography, secondary myocardial infarction due to 
large myocardial mass or low haemoglobin or myocardial infarction due to coronary artery 
spasm 
10
. 
 
During the late 1970s and early 1980s focus shifted towards coronary artery spasm as a 
common cause of MINCA 
11
. However, coronary artery spasm could not be verified as a 
common cause in another study 
12
. In the mid-1980s more cases of myocarditis were presented 
as possible causes of MINCA 
13
. Towards the end of the 1980s several case reports of stunned 
myocardium with concomitant MINCA appeared 
14
. In summary, a multitude of causes to 
MINCA has been postulated through the years although mostly through case reports of only one 
or a few patients (see Figure 1). There have been few researchers that have tried to incorporate 
all possible causes of MINCA into a single larger study. However, for most of this past century 
it has probably been hindered by technology rather than by will. 
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Figure 1. Possible causes of myocardial infarction with normal coronary angiography. 
 
 
 
TAKOTSUBO STRESS CARDIOMYOPATHY 
Takotsubo stress cardiomyopathy (TSC) is a disease where acute and high levels of 
psychological or physiological stress cause reversible hypokinesia of parts of the left ventricle. 
TSC is also known as apical ballooning syndrome, stress-induced cardiomyopathy, broken-
heart syndrome, ampulla cardiomyopathy and various other names. As early as the mid-1970s 
two possible cases of TSC were described when Greenberg et al. and Ciraulo reported on two 
separate cases of MINCA with reversible mid- and apical left ventricular hypokinesia, 
respectively 
15 16
. In 1987 Shaw et al. reported a case involving transient shock and extensive 
myocardial akinesia caused by a pheochromocytoma crisis 
17
. In 1990 Sato et al. described and 
named Takotsubo stress cardiomyopathy (TSC) after a Japanese fishing pot used for trapping 
octopuses 
18 19
. Sato et al. described multivessel spasm occurring either spontaneously or after 
administration of intracoronary ergonovine. In the same study they found that the spasm was 
resolved after intracoronary administration of nitroglycerin.  
 
Figure 2. Possibly one of the first reported cases of Takotsubo stress cardiomyopathy in 1975
16
. 
 
During the 1990s a number of case reports of TSC were 
described, mainly by Japanese authors 
20-22
. TSC 
subsequently became associated with other diseases that is, 
development of TSC after debut of subarachnoid 
hemorrhage and more examples of TSC during a 
pheochromocytoma crisis 
23-25
. This more firmly associated 
TSC with high levels of catecholamines as seen during a 
pheochromocytoma crisis. In a larger study Tsuchihashi et 
al. retrospectively described 88 cases of TSC and their 
clinical features, types of triggering stress and laboratory 
analysis findings 
26
. In other series of TSC patients Bybee et 
 12 
al. studied the clinical manifestations of TSC in an American population, while Desmet et al. 
described what they thought were the first cases of TSC in a white population 
27 28
. Altogether 
these series of case reports led Bybee et al. to propose the Mayo Clinic criteria for TSC (see 
Table 1) 
29
. The Mayo Clinic criteria, however, have recently been questioned mainly because 
of more evidence for non-typical forms of TSC 
30
.  
 
Table 1. Mayo Criteria for the clinical diagnosis of the transient left ventricular apical 
ballooning syndrome 
29
. 
 
 
After the renewed interest in TSC started in the early 2000s, Owa et al. studied four TSC 
patients, assessing myocardial perfusion using 
201
Tallium, fatty acid metabolism using 
123
I-15-
(p-iodophenyl)-3-R,S-methyl-pentadecanoic acid (
123
I-BMIPP) and sympathetic nerve function 
using 
123
I-metaiodobenzyl-guanidine (
123
I-MIBG). They found impairment of all types of 
scintigraphy in the acute phase 
31
. Akashi et al. also studied sympathetic nerve function using 
123
I-MIBG in 8 patients with TSC and found an impaired function 
32
. The report on a case  in 
which both scintigraphy and coronary flow reserve (CFR) had been performed showed severely 
reduced myocardial perfusion and reduced CFR in the acute phase and only mild improvement 
after an additional assessment of perfusion at 15 days, indicating both abnormal perfusion and 
microcirculation in the acute phase 
33
. In a study by Ito et al. seven patients were examined 
using both echocardiography and scintigraphy. Wall motion score, myocardial perfusion, fatty 
acid metabolism and sympathetic nerve function were studied. The examinations showed 
impaired wall motion score, reduced myocardial perfusion (
99m
Tc-Tetrofosmin), impaired fatty 
acid metabolism and impaired sympathetic nerve function 
34
. In conclusion, scintigraphic 
studies to date have shown impaired perfusion, fatty acid metabolism and nerve function in the 
acute phase, with slow recovery over the subsequent months. 
 
Up to the mid-2000s only the most typical shapes of TSC had been described. From then on a 
variety of TSC shapes were described, including reverse TSC with basal hypokinesia 
35
 and 
right ventricular hypokinesia 
36
. A larger study involving 107 North American TSC patients 
found the classical shape in 54%, mid-ventricular hypokinesia in 29% and basal hypokinesia in 
1% 
37
. Other variants including regional hypokinetic patterns constituted the rest. It became 
evident that not only classically shaped Takotsubo-like hypokinetic patterns appear in this 
disease but that rather a multitude of shapes are possible. There is some evidence to support the 
idea that sympathetic nerve distribution contributes to the individual shape of the hypokinesia 
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seen 
38
. We should keep in mind, though, that no cardiovascular magnetic resonance (CMR) 
examination was performed in the above-mentioned studies and CMR can thus result in 
modification of the initial diagnosis, especially in the case of regional hypokinetic patterns, to 
myocarditis or myocardial necrosis (see section on CMR, below). In addition, assessment of 
ventricular function in TSC is possibly also a matter of timing 
39
. Regional remission of 
hypokinesia or other diseases, such as myocarditis, could be the simple answer to some of the 
regional hypokinetic patterns that have been described in the literature. 
 
The classical triggering factor of TSC is an emotional upsetting event. In a large study on 136 
TSC patients by Sharkey et al. 47% had an emotional trigger while a physiological stressor 
could be identified in 42% 
40
. In an even larger meta-analysis Pilgrim et al. identified 28 case 
series comprising a total of 563 patients. They identified an emotional trigger in 44% and a 
physiological stressor in 36% 
41
. Physiological stressors were most often an exacerbation of 
medical disease. In fact, even myocardial infarctions caused by an acute coronary syndrome 
(ACS) or spontaneous coronary dissection have been shown to trigger TSC 
42 43
. 
 
Some researchers have suggested that TSC and left ventricular outflow tract (LVOT) 
obstruction appear in 20–25% of TSC cases 44 45. However, right ventricular TSC cannot be 
explained by LVOT obstruction and neither can basal or mid-ventricular variants 
36
. It could be 
that LVOT obstruction is just an effect of TSC in some patients, not an underlying cause, with 
the hyperdynamic basal myocardium producing a more pronounced LVOT obstruction than 
would otherwise exist. 
 
The typical TSC patient is a postmenopausal woman. There is some evidence that point to 
gender differences in sympathetic nerve regulation and others to gender differences in 
endothelial function 
46 47
, while in an animal model, oestrogen has attenuated TSC 
48
. However, 
no complete explanation of this difference in gender incidence has this far been postulated. 
When it comes to other baseline characteristics of patients with TSC, these have been most 
thoroughly described by Pilgrim et al. In this large meta-analysis, 90% of TSC patients were 
women of a mean age range from 62 to 76 years, hypertension was present in 49% and smoking 
was present in 21% 
41
. In the same meta-analysis troponin elevation was also presented. In 
thirteen case series troponin levels were measured and found to be elevated in 85% of TSC 
cases. In other words, negative troponin does not exclude the occurrence of TSC. 
 
Endomyocardial biopsies have been performed in subsets of a few case series 
22 49-52
. Typical 
histological findings were contraction band necrosis, but also interstitial fibrosis, mild cell 
infiltration and focal myocardial depletion. No histological evidence of myocarditis was found 
and viral antibody titres were negative. 
 
In recent years some researchers have linked TSC to capture myopathy, which for several 
decades has been known to exist in the animal kingdom 
53 54
. However, what most researchers 
describe when examining the dead animals is rhabdomyolys, rather than just cardiomyopathy. 
Extensive rhabdomyolysis with or without cardiomyopathy is different from the clinical picture 
of TSC, in which no skeletal rhabdomyolysis and only light or moderate elevation of cardiac 
troponins are seen. Accordingly, the connection or association between capture myopathy and 
TSC has yet to be scientifically proven. 
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Pathophysiology of Takotsubo stress cardiomyopathy 
Recently there have been attempts to more accurately describe the pathophysiological pathways 
of TSC 
55-60
. However, in the majority of cases these studies have been performed in animals 
and not in humans. Studies on mouse  or rat models have so far shown that TSC is a result of 
the direct effects of high levels of epinephrine on the ventricular myocardium and that at high 
levels epinephrine is negatively inotropic with a switch in 2-adrenoceptor coupling in 
ventricular cardiomyocytes, from the Gs protein signalling pathway to the Gi protein signaling 
pathway. Animal studies have also shown that the density of -adrenoceptors is greatest at the 
apical myocardium of the mammalian heart, which explains the regional nature of the stunning 
in response to high levels of circulating epinephrine after stressful stimuli. Furthermore, there is 
some evidence that cardiac lipotoxicity is associated with TSC. 
 
 
CARDIOVASCULAR MAGNETIC RESONANCE 
Magnetic resonance imaging is a technique that uses strong magnetic fields and radio frequency 
signals to form images of the body. By both releasing and detecting radio frequency signals 
while using oscillating magnetic fields at specific resonance frequencies, computers can 
translate data to form images of the investigated region of the body. Gradients in the magnetic 
field control the orientation of the image while contrast between different tissues is determined 
by the rate at which excited atoms return to their equilibrium state 
61
. Early work on magnetic 
resonance imaging began in the 1950s when Herman Carr produced the first one-dimensional 
image 
62
. In the 1970s Lauterburn and Mansfield developed the technique further using 
magnetic gradients and faster mathematical techniques to produce the first two-dimensional 
images 
63 64
. Work on CMR was already being performed in the 1980s but initial attempts to 
visualize the heart were distorted by respiratory and cardiac motion. These problems were at 
least partially resolved by the introduction of electrocardiographic gating 
65
. The advent of this 
technique, combined with breath-holding techniques and faster scanning techniques, made it 
possible for the field expand to include cine imaging and techniques to characterize the heart 
muscle 
66-68
.  
 
In the field of MINCA, CMR has the potential to play a significant role. It is known that CMR 
can readily identify both myocardial necrosis caused by an occlusive coronary event and 
myocarditis, using gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA) contrast 
69 70
. 
Late gadolinium enhancement (LGE) is a finding according to which gadolinium contrast is 
enhanced in the myocardium (5-20 minutes after injection) and delineates necrotic tissue
71
. The 
transmural extent of LGE has also been linked to myocardial viability; therefore, the technique 
is increasingly used in the investigation of coronary artery disease (CAD) 
72
. See Figure 3 for 
examples of LGE in CMR. 
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Figure 3. Myocardial necrosis (left) and myocarditis (right) on CMR. 
 
 
 
In 2007, for the first time, Assomull et al. studied the role of CMR in MINCA 
73
. By using 
CMR they found an identifiable basis for troponin elevation in 65% of the patients. Myocarditis 
was found in 50% of patients, myocardial infarction (myocardial necrosis) in 12% and 
cardiomyopathy in 3%. Following Assomull et al., Laraudogoitia Zaldumbide et al., Gerbaud 
et al., Chopard et al. and Leurent et al. also investigated MINCA with CMR 
74-77
. However, 
these studies included MINCA patients in different ways. For example, Assomull et al. 
prospectively included patients referred for CMR from 18 hospitals while Laraudogoitia 
Zaldumbide et al. excluded patients with signs of anterior myocardial infarction. No data are 
available on how many of the included patients underwent chest computed tomography 
examination. Thus, several questions remain that these studies have not yet answered. How 
common is MINCA in an ACS clientele? What is the true incidence of TSC? Are the clinical 
characteristics found in previous studies representative for an emergency department setting? 
 
There are also studies involving CMR that have focused entirely on TSC. In 2009 Abdel-Aty et 
al. were the first to demonstrate a left ventricular T2-weighted oedema on CMR matching the 
extent of hypokinesia 
78
. One year later Eitel et al. investigated 37 patients with suspected TSC 
and found LGE consistent with myocardial necrosis in 19% and with myocarditis in 11% 
79
. 
Seventy percent had no signs of LGE; instead, they had an elevated T2-weighted oedema ratio 
and global relative enhancement consistent with TSC. The first study, which included both 
controls and a follow-up CMR after three months, was performed by Neil et al. 
80
. The regional 
extent of myocardial oedema correlated inversely with myocardial strain (except at the apex). 
There was also a direct correlation of the extent of myocardial oedema with peak levels of N-
terminal prohormone of B-type natriuretic peptide (NT-proBNP). Iacucci et al. studied 17 
patients with TSC (without controls) in the acute phase and after four months 
81
. T2-weighted 
images showed oedema matching the extent of regional dysfunction. No cases of LGE were 
observed. In five patients who underwent endomyocardial biopsy, histology confirmed the 
massive interstitial oedema associated with typical contraction-band necrosis. In conclusion, 
oedema visualized by CMR is a characteristic feature of TSC, a circumstance that can be used 
to obtain a more accurate diagnose of TSC in the clinical setting. 
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STRESS TESTS 
Dobutamine stress echocardiography 
Catecholamines have a strong connection to the development of TSC 
41
. Hence, a direct way to 
induce stress is by infusion of a catecholamine. The most commonly used catecholamine for 
stress tests is dobutamine ((RS)-4-(2-[4-(4-hydroxyphenyl) butan-2-yl]aminoethyl)benzene-
1,2-diol). Its primary mechanism is direct stimulation of 1-receptors, but also weak 2-receptor 
stimulation and selective 1 activity. It increases heart rate, myocardial contractility and cardiac 
output, and thus increases myocardial oxygen demand. Dobutamine was developed in the 1970s 
as a structural analogue of isoprenaline 
82
. 
 
The standard dobutamine stress protocol consists of continuous intravenous infusion of 
dobutamine in 3-minute increments, starting with 5 µg/kg/min and increasing to 10, 20, 30 and 
40 µg/kg/min. If >85% of the calculated maximum heart rate is not reached, an additional dose 
of 0.25 mg Atropine (up to a maximum of 1 mg Atropine) is added to the 40 µg/kg/min 
dobutamine infusion 
83
. 
 
Mental stress test 
Since TSC has a strong connection to mental stress, and not a lot is known about the mechanism 
behind this connection, there is reason to devote further study to the connection between TSC 
and mental stress 
41
. In 1935 Stroop studied the effect of the interference of verbal reactions, a 
work that was subsequently developed into the Stroop colour word test 
84 85
. This was based on 
findings published in 1929 in Germany 
86
. The Stroop colour word test has mainly been used to 
measure selective attention, cognitive flexibility and processing speed but has also been used to 
evoke overall mental stress with measurable effects on arterial blood pressure, muscle 
sympathetic nerve activity (MSNA), heart rate and perceived stress. In 1992 Callister et al. used 
both the Stroop colour word test and mental arithmetics (MA) to study the effect of stress 
87
. 
Both types of stress evoked an increase in arterial blood pressure, MSNA, heart rate and 
perceived stress, despite heart rate increases of only 15% and 11%, respectively, in the two 
tests. Mental stress has been studied using MA and been known to increase arterial blood 
pressure, cardiac output and heart rate 
88
. The anger recall interview (ARI) was used to measure 
cardiovascular reactivity in women in a study by Anderson et al 
89
. Mental stress has also been 
studied in patients with CAD in whom an ARI and MA induced a blunted salivary cortisol 
response compared to controls, despite a heart rate increase of only around 7% during stress 
90
.  
 
 
SELF-ESTIMATED ACUTE STRESS 
In stress research self-estimation of stress has previously been applied to long-term stress or to 
medium to long-term effects of acute stress estimated in a post-stress environment. In 1983 a 
perceived stress scale was introduced in an effort to measure long-term stress 
91
. Since the mid-
1990s Acute Stress Disorder (ASD) has been present in the Diagnostic and Statistical Manual 
for Mental Disorders (4th ed.; DSM–IV) 92. The accompanying interview (ASDI) is a 19-
item, dichotomously scored interview schedule that is based on criteria from the DSM (4th 
edition) 
93
. This diagnosis was introduced to describe posttraumatic stress reactions that occur 
between two days and four weeks following a trauma. Towards the end of the 1990s Kudielka 
et al. measured heart rate, adrenocorticotropin (ACTH), free salivary cortisol, total plasma 
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cortisol and heart rates and found significant responses to a stress test 
94
, and a visual 
analogue scale confirmed that the same amount of stress was experienced by young and 
elderly subjects. In a study by Lesage et al. the visual analogue scale was studied and found to 
be at least as discriminating as a questionnaire when it came to highlighting differences in 
stress levels between two groups 
95
. The visual analogue scale is a continuous scale, which has 
been shown to be the preferred scale type for estimating subjective psychometric response (e.g., 
while the patient is experiencing the pain) 
96
. However, for collecting and analysing perceived 
stress in a post-stress environment, a Likert or discrete type of scale can be preferred 
97
. If one 
assumes equal distances between values in a Likert-type scale, it can be interpreted or 
approximated as an interval scale even though in reality it is ordinal. With an interval scale one 
can calculate mean values and standard deviations 
98
. 
 
For Studies II-III of this thesis a Lickert-type 7-grade discrete scale was used. On this scale 0 
means no self-perceived acute stress while 6 means maximum self-perceived acute stress, and 
the distances between each value are assumed to be equal. 
 
 
MYOCARDIAL PERFORMANCE INDEX 
Myocardial performance index (MPI), derived from different time-phases of the cardiac cycle, 
gives an estimate of the overall systolic and diastolic ventricular function 
99
. MPI can be derived 
from both Doppler flow and tissue Doppler measurements, the former being the original version 
used by Tei et al. 
100-102
. Tissue Doppler derived MPI has been shown to correlate better with 
left ventricular ejection fraction and functional capacity compared to pulsed-wave Doppler 
103
 
(figure 4). MPI has been shown to be a sensitive marker for ventricular function 
99
 and in recent 
years has also been shown to be associated with heart failure as well as to be a predictor of 
cardiovascular events in patients with known left ventricular dysfunction 
104-106
. 
 
There are previous case reports involving TSC in which not only the left ventricle but also the 
right ventricle has been affected. There is one case report in which an isolated right ventricular 
involvement is described. Furthermore, in a recent study right ventricular MPI (RV-MPI) was 
shown to be helpful in differentiating obstructive coronary disease from TSC. For this reason it 
would be of interest to study not only left ventricular MPI (LV-MPI) but also RV-MPI 
36 107-109
. 
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Figure 4. Measuring myocardial performance index 
 
 
 
HEART RATE VARIABILITY 
Heart rate variability (HRV) is the physiological phenomenon of variation in the time interval 
between heart beats (figure 5). In 1733 Rev. Stephen Hales became the first person to describe 
the beat-to-beat variation during respiration 
110
. In 1895 Willem Einthoven, using 
galvanometers, became the first person to continuously record the electrical activity of the heart 
111
. In the early 1960s Norman Holter developed a small portable recording device for collecting 
ambulatory ECGs 
112
. This invention sparked further interest in understanding the relationship 
between beat-to-beat variation of heart intervals and heart disease. With the introduction of 
modern signal processing techniques it became possible to analyse more subtle variations in 
beat-to-beat intervals 
113
. 
 
There are primarily two approaches to analysing HRV: time-domain methods and frequency-
domain methods. Time-domain methods are usually easier to calculate, while frequency-domain 
methods can yield more information. Only the normal beats, originating from the sino-atrial 
node, are included in the calculation – hence the term ‘standard deviation of normal-to-normal’ 
(SDNN) intervals. Accordingly, atrial and ventricular arrhythmias are excluded. From this it is 
also possible to calculate mean NN interval, mean heart rate and range (longest NN minus 
shortest NN). Due to the ease of calculating SDNN, it is the most widely used time-domain 
method of HRV 
114
. SDNN measures the overall variability from periodic and random sources. 
 
Several factors affect HRV: cigarette smoking has been linked to low HRV 
115
, beta-blockers 
and ACE-inhibitors increase HRV 
116
,
117
 and, diabetes mellitus and hypertension have been 
shown to decrease HRV 
118
,
119
. In addition, low SDNN has previously been linked to increased 
mortality after acute myocardial infarction 
114
 and increased mortality in the elderly 
120
. 
Recently HRV in a TSC population was studied and compared with controls 
121
. Using a Holter 
24-hour ECG recording HRV was measured on admission to hospital. SDNN was significantly 
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lower in the TSC group compared with controls, although it was normalized a few weeks after 
admission to hospital on a follow-up 24-hour ECG. 
 
Figure 5. R-wave intervals. 
 
 
SALIVARY CORTISOL 
Cortisol, or hydrocortisone, is a steroid hormone or, more specifically, a glucocorticoid, 
produced by the zona fasciculata in the adrenal cortex 
122
. In response to stress and low levels of 
glucose cortisol is released. Its primary functions are to increase blood sugar through 
gluconeogenesis, suppress the immune system, and aid in fat, protein and carbohydrate 
metabolism. It also decreases bone formation. The hypothalamus secretes corticotropin-
releasing factor (CRF) which stimulates the production of ACTH by the anterior pituitary gland. 
ACTH stimulates production of cortisol by the adrenal cortex. 
 
Figure 6. Feedback mechanism for cortisol regulation. 
 
 
 
Salivary cortisol reflects levels of free cortisol in blood 
123
. Since many forms of stress are 
known to increase free levels of cortisol, salivary cortisol can be used in stress research. In fact, 
it is thought of by some researchers as the method of choice for stress research because of the 
ease by which it can be collected and handled. However, the method has known caveats. For 
example, around one third of salivary cortisol is known to be enzymatically converted to 
cortisone in saliva 
123
. In a recent study Kastaun et al. were able to show that salivary cortisol 
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stress response was blunted in 19 TSC patients compared to 20 healthy controls 
124
. Apart from 
the study by Kastaun et al. there are no previous studies on salivary cortisol and TSC. 
 
 
CORONARY FLOW RESERVE 
Early experiments involving assessment of coronary flow and coronary flow reserve (CFR) 
began in the 1970s. CFR is an estimate of the remaining ability to increase flow in a vessel after 
taking into account stenosis, microcirculation and collateral flow. Initially experiments were 
carried out in anaesthetized dogs using contrast medium to induce hyperemic flow 
125
. During 
the second half of the 1970s Cole et al. developed an instrument to measure intracoronary flow 
using a Doppler catheter
126
. In the 1980s digital arteriographic methods were developed to 
assess the CFR during invasive coronary angiography more indirectly 
127
. In the two last-
mentioned studies contrast medium was used to induce coronary hyperemia. The use of better 
pharmacologic substances was subsequently introduced, enabling Serruys et al. to compare 
digital subtraction angiography with intracoronary Doppler flow measurements before and after 
coronary angioplasty using papaverine 
128 129
. They found that the same quantity of CFR that 
can be recruited by transluminal coronary occlusion can also be recruited pharmacologically. 
 
The first attempts to visualize the coronary arteries by using transthoracic Doppler 
echocardiography were made in 1987 
130
. However, it lasted until 1998 when for the first time 
Hozumi et al. calculated CFR using transthoracic Doppler echocardiography with hyperemia 
from intravenous adenosine 
131
. CFR using dobutamine was also studied although via 
transoesophageal Doppler echocardiography that actually has to be considered a semi-invasive 
technique 
132
. They could show that transoesophageal Doppler echocardiography using 
dobutamine was similar in accuracy to assessments using wall motion abnormalities to detect 
ischemia. In a study by Petropoulakis et al. dobutamine and adenosine were compared by using 
two concomitant intracoronary Doppler flow-wires 
133
. They found that dobutamine was better 
suited for detecting ischemia while adenosine was preferred for assessing myocardial perfusion. 
They also showed that after 20 g/kg/min a further increase in dobutamine did not yield any 
additional information regarding ischemia in stenotic vessels (figure 7). 
 
Figure 7. Assessing the flow-velocity curve in the left anterior descending artery. 
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Coronary flow reserve in Takotsubo stress cardiomyopathy 
One possible explanation for TSC could be microvascular dysfunction. Previous studies have 
shown decreased coronary flow reserve (CFR) during the acute phase of TSC 
134 135
. CFR is 
thought to give an estimate of the maximal remaining flow reserve in a vessel, taking into 
account stenosis in the vessel, microvascular circulation and collateral flow 
136
. Several 
studies have shown that CFR may be estimated by non-invasively assessing the intracoronary 
flow velocity 
131 136
. Previously, the effects of dipyridamole, adenosine and cold pressor test 
on invasive and non-invasive CFR have been studied 
134 137 138
. However dobutamine, a 
catecholamine that closely resembles adrenaline and therefore mimics, possibly more 
accurately, an acute TSC-like event, has not been studied regarding its effect on CFR in TSC. 
However, in a study on CAD patients after revascularization by coronary angioplasty, CFR 
using dobutamine was found to correlate negatively with the wall motion score index and 
positively with tissue Doppler imaging peak velocity despite the absence of stenosis 
139
. 
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AIMS 
The hypothesis of this thesis was that: 
 
1. Cardiovascular magnetic resonance imaging facilitates the diagnosis of MINCA. 
2. TSC patients have an increased vulnerability to sympathetic stress measured by MPI. 
3. TSC patients have an increased vulnerability to mental stress measured by MPI, HRV 
and salivary cortisol. 
4. CFR is reduced during dobutamine stress in patients with a previous episode of TSC. 
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METHODS 
 
STUDY I 
Study group 
In Study I, a total of 176 patients were screened from June 2007 until May 2011 at five 
coronary care units in the Stockholm Metropolitan Area. The patients, who were between 35 
and 70 years of age, had chest pain typical for myocardial infarction, ECG showing sinus 
rhythm on admission, elevated troponins and coronary angiography with no or minimal signs of 
atheromatosis. Minimal atheromatosis was defined as irregularities in the vessel wall not giving 
rise to any stenosis >30%. 
Myocarditis was excluded by CMR imaging; some patients with classical features of 
myocarditis or perimyocarditis were not investigated with coronary angiography and were 
therefore not eligible for the study. The first 100 screened patients were investigated with chest 
computed tomography (CT) to exclude pulmonary embolism. Because all chest CTs were 
normal in these patients the protocol was changed to D-dimer and chest CT was only performed 
upon suspicion of pulmonary embolism.  
 
 
Figure 8. Time-chart for the different studies in this thesis. 
 
 
 
 
 
 
 
 
 
CMR imaging protocol 
A standard CMR protocol included standard steady-state free precession (SSFP) cine imaging 
and T2-weighted oedema imaging, and late gadolinium enhancement (LGE) for fibrosis 
detection was used. The CMR protocol differed slightly between the different sites. The 
investigation was performed with the patient in the supine position using a cardiac coil by 
means of one of three 1.5 T system models (General Electric Healthcare, Signa Excite 
TwinSpeed, Waukesha, Wisconsin, USA; Siemens Sonata, Erlangen, Germany; or Philips 
Intera CV, Best, Netherlands) during vector-ECG monitoring. The image protocol included 
scout images, localization of the short axis and then covering of the whole left ventricle (LV) 
with retrospectively gated cine SSFP images. The following parameters were typically used: 
SSFP (echo time [TE] 1.6-3.3 ms, repetition time [TR] 2.8-3.6 ms, flip angle 60º, 25 phases, 8 
mm slice, no gap, matrix , 160-226x141-226). T2-weighted images (triple inversion recovery; 
TE: 60-80 ms, TR: 2 R–R interval, TI: 150-170 ms, slice thickness 8 or 14 [14 mm with GE 
TwinSpeed] mm, gap 8 mm, flip angle: 90-180 degrees, matrix 226-256x226-256) were 
acquired in the same long- and short-axis planes. LGE images were acquired 15-20 min after 
contrast injection of intravenous gadolinium-DTPA (0.2 mmol/kg) using a 2D or 3D (3D with 
Study entry 
Study I 
MR-screening 
20 months  
Study II&IV 
TSC patients 
28 months 
Study III&IV 
TSC patients 
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Philips Intera CV) inversion recovery gradient echo sequence 2D or 3D (TE 1.1-3.3 ms, TR 3.8-
7.0 ms, inversion time 180-300 ms to null the myocardium, 8 mm slice, no gap, matrix 240-
256x180-192) in the same slice orientation as cine SSFP images. Each slice was obtained 
during end-expiratory breath-holding. Two-, three- and four-chamber views were also obtained 
to confirm the findings. 
 
CMR analysis 
All CMR images were analysed offline, using freely available segmentation software (Segment 
V.1.8 R1405; http://segment.heiberg.se/). Two independent experts with vast CMR experience 
carried out the interpretation of the CMR examinations. All clinical data were blinded and the 
interpretation was done without prior knowledge of the CMR report from the investigating 
hospital, thereby minimizing inter-hospital variation. In case of disagreement, a third CMR 
specialist was consulted to obtain a consensus.  
End-diastolic and end-systolic volumes were measured in the phases with the largest and 
smallest LV volumes, respectively. LVEF, stroke volume and LV mass were calculated on cine 
SSFP sequences using manual delineation of the endocardial and epicardial borders including 
papillary muscles and trabeculations when contiguous with the left ventricle. LV mass was 
calculated by multiplying the myocardial volume by the density of myocardial tissue (1.05 
g/ml). All volumes were indexed to body surface area. 
T2-weighted images were visually interpreted to detect areas of high signal compatible with 
oedema. LGE images were assessed for subendocardial enhancement in the distribution of a 
coronary artery suggesting myocardial infarction or midwall/subepicardial enhancement 
suggesting myocarditis. Patients with patchy involvement on LGE (intramyocardial, including 
both subepicardial and subendocardial) were considered to have myocarditis. Examinations 
with normal volumes and function and with no LGE or T2-weighted abnormalities were 
considered normal CMR examinations.  
 
STUDY II 
Study group 
Twenty-two patients with a previous episode of TSC and 22 sex- and age-matched controls 
were investigated using DSE. The TSC patients and controls were recruited from the SMINC 
(Stockholm Myocardial Infarction with Normal Coronaries) study. All TSC patients had a 
previous normal CMR. The controls were not investigated using coronary angiography prior to 
their inclusion in the study but had no signs or symptoms of coronary artery disease and a 
previous normal exercise stress test. Study II was performed a mean 20 months after the acute 
event (see Figure 8). 
 
Echocardiography 
A Philips (Amsterdam, Netherlands) iE33 was used for echocardiography. First, the left 
ventricular ejection fraction (EF) and function of the mitral, tricuspid and aortic valves were 
recorded. Transmitral flow was recorded by pulsed-wave Doppler placed between the mitral 
leaflet tips in an apical four-chamber view. Early (E) and late (A) transmitral flow velocities 
were recorded. The ratio of early-to-late transmitral peak velocities (E/A) and the deceleration 
time (DT) were obtained and calculated. The pulsed-wave Doppler tissue imaging (DTI) was 
performed by activating the DTI function. Images were acquired by using a variable-frequency 
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phased array transducer. The filter settings were kept low (50 Hz) and gains were adjusted at the 
lowest possible level to minimize noise and eliminate the signals produced by the transmitral 
flow. A 4.0 mm sample volume was used. Four sites at the LV were selected. A Doppler 
velocity range of -15 to 15 cm/s was selected. In the apical four-chamber view, the DTI cursor 
was placed near the septal and the lateral sites of the mitral annulus. In a similar way, the 
velocities at the anterior and inferior sites of the LV were recorded from the apical two-chamber 
view. A mean value was calculated from the above four sites and used to assess the LV-MPI 
and left ventricular filling pressure (E/E´ -ratio of transmitral early wave and DTI-derived early 
diastolic velocity). The tricuspid annular velocities were also measured similarly by placing the 
sampling volume near the tricuspid ring of the RV free wall in the apical four-chamber view. In 
this way the RV-MPI was calculated. MPI was calculated by measuring the isovolumetric 
contraction time (IVCT), isovolumetric relaxation time (IVRT) and ejection time (ET) and 
derived from (IVCT+IVRT)/ET. An example of how MPI was measured can be seen in Figure 
1. The images obtained with echocardiography were analysed in Syngo Dynamics software 
(Siemens Healthcare, Erlangen, Germany). A mean of three consecutive cycles was used to 
calculate all echo-Doppler parameters. 
 
Dobutamine stress echocardiography 
Dobutamine stress echocardiography (DSE) was performed according to the consensus 
statement of the European Association of Echocardiography 
83
. An increasing dose of 
dobutamine was administered (5, 10, 20, 30 and 40 ug/kg/min) until the heart rate reached 
>85% of the calculated maximum heart rate. If necessary, at the highest dose of dobutamine, an 
additional dose of atropine was administered to reach the calculated maximum heart rate. At the 
highest dose of dobutamine E/A, E/E´, LV-MPI and RV-MPI were assessed. 
 
 
STUDY III 
Study group 
The TSC patients (n=22) and controls (n=22) in Study III were investigated by applying mental 
stress, and the study group was almost identical to the study groups in Study II (see Study III for 
a complete description of the study groups). For the HRV data 18 TSC patients and 20 controls 
were investigated because that part of the study was started after the overall study. Study III was 
performed a mean two years and four months after the acute event (see Figure 8). 
 
Mental stress 
The mental stress test consisted of two parts. The first part was an anger recall interview 
140 141
 
in which the patient and control were asked to recall an upsetting situation in the few months 
prior to the investigation and then speak about that situation for a few minutes. A few follow-up 
questions were asked by the interviewer about this upsetting situation. The second part of the 
mental stress was a mental arithmetic task 
140 142
 that was performed directly after the anger 
recall interview. The patient or control was asked to subtract 7 from 200 in continuing steps as 
fast as possible. This test was done with increasing stress by the interviewer. 
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Self-estimate acute stress 
In a post-stress environment the TSC patient and the control were asked to estimate their level 
of recently experienced mental stress on a Likert-type discrete 7-grade scale (0-6). The TSC 
patients were also asked to estimate (on the same Likert-type scale) the level of acute stress they 
experienced during the acute event. 
 
STUDY IV 
Study group 
The study groups consisted of 22 patients with a previous episode of TSC and 22 sex- and age-
matched controls. The two independent groups in this study were investigated using CFR (see 
CFR section below) during dobutamine and mental stress, and the study groups were similar to 
those in Studies II and III, depending on the type of stress used.  
 
Coronary flow reserve 
All patients and controls were investigated using dobutamine and mental stress. A Philips 
(Amsterdam, Netherlands) iE33 was used to obtain echocardiograms. First, the left ventricular 
(LV) ejection fraction (EF) and function of the mitral, tricuspid and aortic valves were recorded. 
For the flow-velocity recordings a 3.5 Mhz high-frequency probe was used. The filter settings 
were kept at 150 Hz and gains were adjusted at the lowest possible level to minimize noise. A 
10 mm sample volume was used. A Doppler velocity range of -15 to 15 cm/s was selected. At 
rest the flow-velocity curve of the left anterior descending (LAD) artery was assessed from an 
apical two-chamber view. If necessary, SonoVue (Bracco, Milano, Italy) contrast was used to 
enhance the flow-velocity signal. Non-invasive CFR was calculated from the peak diastolic 
velocity in LAD at rest, low-dose and high-dose dobutamine, where CFR is the velocity during 
stress divided by velocity at rest. A mean of three consecutive cycles was used to calculate all 
parameters. 
 
In the manuscript (Study IV), only the results of dobutamine stress were published.  
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RESULTS AND DISCUSSION 
 
STUDY I: MYOCARDIAL INFARCTION WITH NORMAL CORONARY ARTERIES 
IS COMMON AND IS ASSOCIATED WITH NORMAL FINDINGS ON 
CARDIOVASCULAR MAGNETIC RESONANCE - RESULTS FROM THE 
STOCKHOLM MYOCARDIAL INFARCTION WITH NORMAL CORONARIES 
STUDY. 
 
The baseline characteristics for Study I can be seen in Table 2. 
 
Table 2. Baseline characteristics for Study 1. 
 I 
All 
screened 
n=176 
II 
All CMR 
 
n=152 
III 
Myocarditis 
on CMR 
n=11 
IV 
AMI on 
CMR  
n=29 
V 
Normal 
CMR 
 
n=102 
 
Comparison 
between groups 
III, IV and V 
(p-value) 
Age, years 58.5 58.0 48.0
*
 57.0
# 
59.0 0.04  
Female 112 (63) 98 (64) 6 (55) 12 (43) 73 (72) <0.01 
Current smoking 27 (15) 25 (17) 0 (0.0) 3 (11) 19 (18) 0.21 
Prior smoking 66 (37) 56 (37) 3 (27) 15 (50) 35 (34) 0.33 
Family history of 
CAD 
51 (29) 43 (28) 4 (36) 3 (11) 34 (33) 0.04 
Diabetes 
mellitus 
7 (4) 6 (4) 0 (0.0) 2  (7) 3 (2) 0.17 
Treated 
hypertension 
58 (33) 52 (34) 2  (18) 9 (32) 35 (35) 0.63 
Treated 
hyperlipidemia 
22 (13) 19 (13) 3 (27) 2 (7) 11 (11) 0.17 
Normal ECG 94 (53) 81 (53) 8 (73) 16 (54) 53 (52) 0.47 
 28 
Values are in number of patients (or percentage). Maximum troponin level (times above normal) and age are median values. 
CMR: cardiovascular magnetic resonance; AMI: acute myocardial infarction; CAD: coronary artery disease; ECG: 
electrocardiography. Initially all groups were compared in order to detect any significant differences. *p = 0.02 vs. group V, #p < 
0.01 vs. group V.  
 
According to RIKS-HIA, the total number of patients in the Stockholm Metropolitan Area with 
ACS from June 2007 to May 2011 was 4412. Of these 277 had MINCA, according to SCAAR
1
. 
Thus, during the inclusion period we screened in total 64% of all of the eligible MINCA 
patients. The study flow of Study I can be seen in Figure 9. 
 
Figure 9. Study flow of Stockholm Myocardial Infarction with Normal Coronaries study 
 
 
Results of cardiovascular magnetic resonance 
In 102 patients CMR was normal. Twenty-nine patients had signs of myocardial necrosis and 
11 patients had signs of myocarditis. With 10 patients, either they had hypertrophic 
cardiomyopathy or their CMR diagnosis was not conclusive. The CMR results can be seen in 
Figure 10. Twenty-two percent of all patients screened with CMR fulfilled the Mayo Clinic 
criteria for TSC
29
. 
  
Chest CT scan 
Cardiac MRI 
(n=152) 
Pulmonary 
embolism (n=0) 
Positive 
All AMI[1] 
(n=4412) 
Claustrophobia or 
no CMR (n=24) 
All MINCA [1] 
(n=277 or 6.3% of 4412) 
Negative 
All patients screened in this study 
(n=176 or 63.5% of 277) 
[1] Data from the Swedeheart 
registry  
Maximum 
troponin level 
(times above 
normal) 
25.5 25.7 30.7 60.5# 16.6 <0.01 
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Figure 10. Pie chart of cardiovascular magnetic resonance results. 
 
 
The diagnosis of TSC demands further comments. The reversible hypokinesia found in TSC is 
time-dependent and can sometimes be difficult to assess. In Study I we have no exact data as to 
the extent to which left ventricular angiography or echocardiography were used. Nor is the 
extent to which these investigations were used evident in previous studies involving CMR in 
MINCA patients. 
73-76 143 144
. If left ventricular angiography and echocardiography are 
performed soon after admission to hospital the incidence of TSC would most probably be 
higher since it would enhance the possibility of demonstrating the myocardial dysfunction 
typical of TSC.  
 
One important finding of Study I is that CMR increases the number of patients who receive a 
proper diagnosis. By using CMR we found that around half of all MINCA patients received a 
correct diagnosis, while more than half of the patients reported having received a different 
diagnosis after CMR that what they had at discharge. This finding has important implications 
for the prognosis and medical treatment of MINCA patients. 
 
As already mentioned in the Introduction section above, there are previous studies that have 
used CMR on a MINCA population 
73-76 143 144
. What separates Study I from the other studies is 
that all of the patients in the Stockholm Metropolitan Area who were between 35 and 70 years 
of age were eligible for our study, while in the other studies there was a younger clientele and 
higher incidence of myocarditis. We chose to exclude patients who were younger than 35 in 
Study I, so that coronary angiography would be clinically motivated. The CMR in our study 
was performed at a median of 12 days after admission to hospital. In previous studies the time 
from admission to CMR varies substantially. In the study by Stensaeth et al. the median time to 
CMR was only 20 hours 
143
. In a larger study by Gerbaud et al. time to CMR was a median 6.2 
days 
75
. In two other studies this information is not available 
74 144
, while in a study by Chopard 
et al. it was 10 days 
76
. The time to CMR has important clinical implications for the diagnosis of 
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TSC since the systolic dysfunction often disappears within one week. It also has implications on 
the extent to which myocardial oedema can be assessed in TSC patients. 
 
 
STUDY II: VULNERABILITY TO SYMPATHETIC STRESS DOES NOT PERSIST IN 
TAKOTSUBO STRESS CARDIOMYOPATHY 
The mean age of both groups was 62.9 years. In both groups, all but one individual were 
female. Current smoking and treatment with beta-blockers were more common in the TSC 
group. Baseline characteristics are shown in Table 3. 
 
Table 3. Baseline characteristics 
 Takotsubo Control p-value 
Number 22 22 n.a. 
Age (years, mean value) 62.9 62.9 n.a. 
Gender (male/female) 1/21 1/21 n.a. 
Currently a smoker 18% 0% 0.04 
Diabetes mellitus 4.5% 0% 0.33 
Hypertension 45.5% 22.7% 0.12 
Beta-blocker 50% 13.6% 0.01 
Calcium blocker 18.2% 0% 0.04 
ACE inhibitor 45.5% 13.6% 0.02 
ECG: electrocardiography; ACE: angiotensin converting enzyme; n.a.: not applicable 
 
At rest there were no significant differences in conventional DTI parameters between the 
groups, whereas LV-MPI differed significantly between the groups (see Table 4). 
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Table 4. Baseline echocardiographic data. 
 Takotsubo Control p-value 
E/A 0.90 1.01 0.26 
DT 180 187 0.58 
E/E´ 8.20 7.90 0.48 
LV-MPI 0.59 0.53 0.01 
RV-MPI 0.47 0.38 0.08 
EF: ejection fraction; E/A: early and atrial transmitral flow fraction; DT: deceleration time; E/e´: early transmitral flow and early 
tissue Doppler velocity fraction; LV-MPI: left ventricular myocardial performance index; RV-MPI: right ventricular MPI. 
 
During DSE there were no significant differences between the groups in standard diastolic 
variables, LV-MPI (0.80 and 0.91, p=0.43) or RV-MPI (0.69 and 0.81, p=0.32). 
 
Data from registries and retrospective studies show that recurrence of TSC is rare 
41 145 146
. 
There have been some reports of episodes of TSC being triggered by performing a DSE 
147 148
. 
Previously no one has investigated TSC patients using catecholamine stress. Accordingly, the 
results of Study II are of interest. Of 22 TSC patients we could not precipitate a second TSC 
event in any of them. In fact we could not even distinguish the TSC group from controls when 
using sensitive DTI. The DTI technique used was MPI. MPI has been shown to sensitively 
assess LV function and functional capacity, and it correlates with mortality and an increased 
risk of developing heart failure 
103 104
. 
 
Our conclusion from Study II is that it seems as if the previous vulnerability to catecholamine 
stress does not persist after the acute event in TSC patients. However, one possible explanation 
for the lack of negative inotropic response to dobutamine stress is the fact that dobutamine only 
has a weak beta2 effect. In animal studies the negative inotropic effect at high catecholamine 
doses is mediated via the beta2-receptors 
57 59
. Shao et al. induced a TSC-like pattern in rats 
using isoprenaline (a non-selective beta-adrenergic agonist
149
) and Paur et al. produced apical 
depression of myocardial function using epinephrine (non-selective alpha and beta adrenergic 
agonist
150
). The apical depression in the latter study could be prevented by pertussion toxin 
infusion and G(i) inactivation. Hence, dobutamine, despite being a catecholamine, could 
possibly be insufficient to precipitate a TSC event even at high doses. Thereby, the exact 
mechanism for precipitating TSC and the rarity of persisting vulnerability to stress in TSC 
patients still needs to be explored further.  
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STUDY III: NO MYOCARDIAL VULNERABILITY TO MENTAL STRESS IN 
TAKOTSUBO STRESS CARDIOMYOPATHY 
 
Twenty-two TSC patients and 22 sex- and age-matched controls were investigated with DTI. 
The mean ages of the groups were 63.2 and 63.6 years, respectively. Current smoking and beta-
blockers were more common in the TSC group. See Study III for a complete description of the 
baseline characteristics of both groups. 
 
Mental stress test 
All TSC patients and controls completed the mental stress test. At rest the heart rate for the TSC 
patients was 58 beats per minute (bpm), and for the controls, 60 bpm. During peak stress they 
reached 89 and 94 bpm, respectively (p=0.28). 
In this study we used ARI and MA as our mental stress tests 
88 89
. That both types of stress can 
induce a cardiovascular reaction was validated previously. We could possibly have induced a 
greater amount of stress in the TSC patients and controls using the Stroop colour word test or 
other mental stress test 
84
. However, since we had already achieved 53% and 57% increases in 
heart rate for TSC patients and controls, respectively, the additional effect of, for example, a 
Stroop colour word test would have been limited. Furthermore, there are ethical reasons for 
limiting the amount of stress we induce on patients or controls. 
 
Myocardial performance index 
LV- and RV-MPI did not differ significantly between TSC patients and controls at rest or 
during mental stress. 
Our conclusion from Study III is that there is no remaining vulnerability to mental stress in TSC 
patients measured by sensitive tissue Doppler (MPI). To our knowledge, there are no previous 
studies on LV- or RV-MPI and mental stress performed in the non-acute phase. However, in 
one previous study Bhat et al. compared RV-MPI assessed during the acute phase in 17 patients 
with TSC and 46 patients with obstructive LAD disease 
109
. They found that RV-MPI was 
significantly higher in TSC patients compared to in patients with obstructive LAD disease (1.03 
versus 0.44, p<0.001). Hence, there are indications that MPI is pathological in the acute phase 
while no significant difference in RV- or LV-MPI can be seen in TSC patients compared to 
controls during mental stress more than six months after the acute event. 
 
Heart rate variability 
For the HRV data, 20 TSC patients and 18 controls were studied. The HRV part of the study 
started after the DTI and SC parts – hence the lower number of TSC patients and controls 
examined with HRV. The duration of Holter-ECG was 32 minutes and 30 minutes for the TSC 
patients and controls, respectively. Overall SDNN was 61 and 76 ms for TSC patients and 
controls, respectively (p=0.21) while SDANN was 41 and 47 ms, respectively (p=0.19). 
SDANN pre-stress was 11 ms and 16 ms for TSC patients and controls, respectively (p=0.11). 
Both groups increased significantly in SDNN from pre-stress to during stress (p=0.002). 
Excluding beta-blocker treated TSC patients or controls, there was a trend towards a greater 
increase in SDNN from pre-stress to during stress in the TSC group (p=0.055). There was no 
significant difference between the groups post-stress. 
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Salivary cortisol 
The second basal SC measurement, taken 30 minutes after waking-up, was 12.4 and 17.3 
nmol/L in TSC patients and controls, respectively (p=0.25). The difference in SC before and 
after mental stress was -0.6 and 0.6 for TSC patients and controls, respectively (p=0.099). In all 
other measurements no significant differences could be seen between the groups. 
 
Both HRV and SC responses were normal for the TSC group. One could speculate as to 
whether a larger study sample would have been able to show a difference in HRV or SC. In our 
study there was a tendency toward less of an increase in SC both after waking up and after a 
stressful event. A recent study that compared 19 TSC patients, 20 patients with non-ST 
elevation myocardial infarction and 20 healthy controls found a trend towards a blunted salivary 
cortisol response in the TSC patients compared to healthy controls after correction for 
differences between both groups 
124
. That study was performed a mean 18 months after the 
index event and the result was achieved despite a heart-rate increase of only 6%. In our study 
(Study III), we also noted a trend towards a blunted SC response in TSC patients while 
increasing the heart rate by 53% during mental stress. One explanation for the non-significant 
results could be that salivary cortisol measurements have high intrinsic variability, which 
inhibits our ability to effectively assess differences in salivary cortisol response between TSC 
patients and controls 
123
. 
 
 
STUDY IV: CORONARY FLOW RESERVE DURING DOBUTAMINE STRESS FOR 
TAKOTSUBO STRESS CARDIOMYOPATHY 
 
Baseline characteristics of Study IV were similar to those of Studies II and III, depending on the 
type of stress used when assessing CFR (see Study IV for a complete description of baseline 
characteristics). 
 
Coronary flow reserve 
There were no significant differences in heart rate between the groups at any point. Resting 
heart rate was 68 beats per minute (bpm) and 68 bpm for the TSC patients and controls, 
respectively, while heart rate at low-dose dobutamine was 99 bpm and 94 bpm, respectively. 
Maximum heart rate at high-dose dobutamine was 131 bpm and 134 bpm for TSC patients and 
controls, respectively.  
CFR at low-dose dobutamine was significantly lower in the TSC group compared to controls: 
1.51 and 1.72, respectively (p=0.017). At high-dose dobutamine CFR was 1.95 and 2.21 in the 
TSC group and controls, respectively (p=0.098).  
We also studied CFR during mental stress. These data were not included in Study IV but are 
shown below (see Table 5). During both ARI and MA there were no significant differences 
between the groups. 
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Table 5. Coronary flow reserve during mental stress. 
 Takotsubo Control p-value 
CFR ARI 1.51 [±0.30] 1.43 [±0.24] 0.35 
CFR MA 1.49 [±0.35] 1.53 [±0.25] 0.67 
CFR: coronary flow reserve; ARI: anger recall interview; MA: mental arithmetics. 
 
Several studies have investigated CFR using adenosine or dipyridamole 
134 137 138
. In conclusion, 
these studies show that CFR measured using adenosine or dipyridamole is pathologic in the 
acute or sub-acute phase but normalized after some weeks or a few months. There have been no 
previous studies on TSC patients with CFR using dobutamine stress. In study IV, which 
involved the use of dobutamine stress, at one year and eight months after the acute event CFR 
was similar to controls at high-dose dobutamine but still significantly lower compared to 
controls at low-dose dobutamine. There are three possible explanations for this: firstly, we 
induced a mild microvascular dysfunction in TSC patients using dobutamine stress that is 
only significant compared to controls at low-dose dobutamine. The possible explanation for a 
non-significant result during high-dose dobutamine is the challenging assessment of coronary 
flow. Secondly, CFR is pathological after the acute event (and only assessable when using 
dobutamine). The differences between points 1 and 2 would be that microvascular 
dysfunction is either induced during stress or is chronically impaired. Thirdly, baseline 
characteristics are the explanation for pathologic CFR during low-dose dobutamine stress and 
not the fact that these are patients with a previous episode of TSC. In all three instances a 
more challenging assessment of peak coronary flow velocity could have influenced the results 
at high-dose dobutamine. In other words, a large variation in means at high-dose dobutamine 
might have obscured a true significant difference between TSC patients and controls. 
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GENERAL DISCUSSION 
 
 
Baseline characteristics of MINCA 
In order to compare our group of MINCA patients with previous studies of MINCA, using 
CMR, the baseline characteristics with and without our patients in study I are shown in Table 6.  
 
Table 6. Meta-analysis of baseline characteristics in studies on MINCA with CMR. Column A: 
Study I; Column B: patients from study [72-76]; Column C: patients from study [72-76] + 
Study I. 
Total number of patients A n=152 B n=464 C n=616 
Mean age 58.0 (years) 49.0 (years) 51.2 (years) 
Male sex 35 60 54 
Family history of CAD
#
 28 27
#
 28
##
 
Smoking
#
 37 38
#
 37
##
 
Hypertension
#
 33 33
#
 33
##
 
Diabetes mellitus
#
 4 7
#
 6
##
 
Myocarditis on CMR 7 44 35 
Acute myocardial infarction on CMR 19 21 20 
Takotsubo stress cardiomyopathy 22 14 16 
Percentage; CAD: coronary artery disease; CMR: cardiovascular magnetic resonance; #/##For these characteristics, #n=277 and 
##n=429, respectively. 
 
This meta-analysis shows that MINCA patients are not very different in baseline characteristics 
from patients with known CAD with smoking and hypertension being more prevalent in 
comparison to controls 
151
. In comparison to previous studies [72-76] our MINCA group 
showed an increase in age, decrease in male sex and, most evidently, a drastic decrease in 
myocarditis. Previous studies included younger patients, whereas in Study I we restricted 
inclusion to patients between 35-70 years of age. The reason for this was to eliminate young 
patients with myocarditis; moreover, TSC is rare in patients <35 years of age. However, 
remaining baseline characteristics in our study, such as family history of CAD, smoking, 
hypertension and diabetes mellitus, seem to correspond with earlier studies.  
 
A recent meta-analysis by Pasupathy et al. found that the prevalence of MINCA was 6% 
152
. 
This analysis was done using 28 previous studies. Median age was 55 years but only 40% were 
women. In this study Pasupathy et al. also performed an analysis of all-cause mortality and 
found that it was 4.7% in MINCA compared to 6.7% in myocardial infarction with obstructive 
coronary artery disease. Although we did not perform an analysis of mortality in Study I it is 
interesting to compare clinical characteristics in column C (Table 6) with the meta-analysis by 
Pasupathy et al. It is quite obvious that most of the clinical characteristics are similar. Also the 
prevalence of MINCA calculated in Study I was similar to the one calculated by Pasupathy et 
al. (6.3 versus 6%). 
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Regression of systolic and diastolic dysfunction in TSC patients 
When combining the results of Studies II-III one could draw the conclusion that vulnerability to 
catecholamine and mental stress for TSC patients does not persist or is rare at least. 
Furthermore, Studies II-III could also imply that sensitive DTI can assess a noticeable decrease 
in combined systolic and diastolic function that persists for many months after the acute event. 
Since all but one TSC patient or control in each group were the same in both Study II and Study 
III the median value of MPI at rest should be reliable. Furthermore, this could correspond to 
TSC patients’ experience, seen in clinical practice, with a raised level of fatigue and reduced 
level of physical activity long after the acute event 
153
. Decreased systolic and diastolic function 
as well as heart failure symptoms also correspond to data showing elevated levels of N-terminal 
pro-hormone brain natriuretic peptide (NT-proBNP) in TSC patients three months after the 
acute event 
154
. A recent study by Neil et al. found that an impaired global longitudinal strain 
(GLS) at three months was associated with both persistent NT-proBNP elevation and a reduced 
Short-Form Health Survey Physical Composite Score (SF36-PCS) at three months 
153
. In 
conclusion, there is some evidence for a persistent reduction and a slow long-term regression of 
left ventricular function in TSC patients. However, the exact mechanism by which a TSC 
episode regresses over time needs to be further explored. See Figure 10 for a time-chart of the 
regression of systolic and diastolic dysfunction in TSC. 
 
 
Figure 10. Regression of systolic and diastolic dysfunction in TSC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Our findings of a normalization of systolic and diastolic ventricular function as well as normal 
HRV and SC, at rest and during stress, indicate and strengthen an excellent prognosis for 
patients with TSC. This may bring long-term therapy using beta blockers or other medications 
in TSC patients into question. 
 
Pathophysiology of TSC 
What do Studies II-IV add to our current knowledge about the pathophysiology of TSC? 
Dobutamine and mental stress did not induce any wall-motion abnormalities measured using 
sensitive DTI, nor could we induce any microvascular dysfunction at high-dose dobutamine. 
Consequently, we can conclude that the vulnerability of ventricular function (or 
microvascular function) to the level of stress we did achieve did not persist in our group of 
Acute event 20 months 
(Studies II&IV) 
12 days (Study I) 28 months 
(Studies III&IV) 
Systolic & 
diastolic 
dysfunction. 
Elevated 
NT-proBNP 
Normalization 
of systolic 
function. 
Diastolic dysfunction 
by Doppler tissue 
imaging. Pathological 
coronary flow reserve 
(low-dose dobutamine 
stress) 
Normalization of 
diastolic function by 
Doppler tissue 
imaging. Normal 
coronary flow reserve 
(mental stress) 
Still elevated NT-
proBNP. Impaired 
global longitudinal 
strain and reduced Short 
Form 36 – Physical 
Composite Score. 
3 months  
 37 
 
TSC patients. However, we found a small but significant difference in CFR at low-dose 
dobutamine. This could imply that microvascular function has a role in the pathophysiology 
of TSC. Further studies in this area are needed.  
In a recent meta-analysis with the aim of identifying predisposing factors of TSC, Pelliccia et 
al. found that the most common comorbidities of TSC were psychological disorders (24%), 
pulmonary disease (15%) and malignancies (10%) 
155
. Furthermore, hypertension was present 
in 54%, dyslipidemia in 32%, diabetes mellitus in 17% and smoking in 22%. This meta-
analysis was done using 19 studies and 1,109 patients with a mean age spanning from 59 to 
76 years. Compared to our small sample in Studies II-IV these clinical characteristics are 
similar except for diabetes mellitus which was much less common among our TSC patients. 
Comorbidities were not analysed in our sample for Studies II-IV, but psychological disorders, 
chronic obstructive pulmonary disease and malignancies were identified among the larger 
group of TSC in Study I (in manuscript). 
Mortality among TSC patients have been disputed in the past (see table 7 below). In order to 
get an overview of previous studies on mortality in TSC patients I compiled mortality-data 
from previous studies in table 7. 
Table 7. Mortality in Takotsubo stress cardiomyopathy 
 Mortality (%) 
Author Year N= CMR In-
hospital 
30-day 1-year Other Comment 
Pilgrim et al.41 2008 563 No 1.7    Meta-analysis 
Buja P et al.156 2008 28 No    10.7 (2 years)  
Dib C et al.157 2009 105 No    12-14 (5 years)  
Sharkey W et al.40 2010 136 Yes   6.8  95/136 performed CMR 
Song BG et al.158 2010 87 No 9   23 (42 months) 0% cardiac 
Schultz T et al.159 2012 115 No 6   10 (3 years)  
Brinjikji W et al.160 2012 24701 No 4.2    81% had critical illness 
Kwon SW et al.161 2013 208 No 8.7     
Weihs V et al.162 2013 179 No 0.6 1.3  6.7 (2 years) 10/13 non-cardiac 
Prasad et al.163 2014 12 No    0 (2 years) HORIZONS-AMI 
substudy 
Citro R et al.164 2014 227 No 2.6     
Reglat C et al.165 2014 70 No    8 (4.8 years)  
Singh K et al.146 2014 2120 No 4.5    Meta-analysis 62% non-
cardiac 
Isogai T et al.166 2014 3719 No 5.4 and 
17.9 
   Out-of-hospital and in-
hospital TSC 
Nunez Gil IJ et al.167 2014 202 No 2.4     
Bennett J et al.168 2014 139 No 6.9  12.6   
Redfors B et al.169 2015 302 No  4.1   SWEDEHEART  
Percentage. N; number of patients, CMR; cardiovascular magnetic resonance, TSC; Takotsubo stress cardiomyopathy 
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Of all studies performed on TSC and mortality since 2008 only one used CMR. In other 
words, the quality of the TSC diagnosis should be improved in future studies. In several 
studies non-cardiac death is surprisingly high. Hence, the exact mechanism by which TSC 
patients die requires further investigation. Furthermore, one can also question the connection 
between mortality and a TSC event in many instances. Critical illness, malignancy or other 
severe co-morbidities could be the more accurate reason why a patient does not survive the 
first year after a TSC event. However, several studies indicate an increased mortality during 
the first one to two years after a TSC event and this can probably not be entirely explained by 
co-morbidities. Further studies in this field are needed. 
 
Self-estimated acute stress 
Directly after dobutamine and mental stress were performed the patients and controls were 
asked to estimate their level of acute stress during each type of stress. The TSC patients were 
also asked to retrospectively estimate their acute level of stress during the TSC episode itself. 
Self-estimated acute stress level (Likert-type scale 0–6) during mental stress was 2.7 and 2.6 for 
TSC patients and controls, respectively (p=0.81). During dobutamine stress the self-estimated 
acute stress was 3.0 and 4.0 in TSC patients and controls, respectively (p=0.05). TSC patients 
estimated that their stress level was 4.4 on the same Likert-type scale during the acute event.  
 
There could be several explanations for this result. Firstly, the TSC patients could be used to 
high levels of stress, a hospital environment and investigations and therefore not find the 
dobutamine stress so stressful. Secondly, the TSC patients could have become less vulnerable to 
catecholamine stress after the real TSC event. In other words, a more direct biological effect can 
explain the difference in perceived acute stress. Mental stress was estimated in a similar way 
between both groups (2.7 and 2.6, respectively; p=0.81). Consequently, mental stress achieved a 
significantly lower level of stress than did both dobutamine stress and the acute event (for the 
TSC patients) and did not differ between controls and TSC patients. Even though the acute 
event for the TSC patients was estimated more than one year later, the results give us an 
indication that both the heart rate and general stress level achieved during dobutamine stress in 
the controls was not very far from what the TSC patients experienced during the acute event. 
 
As already mentioned in the Introduction section, no previous study has been performed where 
a Likert-type scale of self-estimated acute stress has been assessed. Several studies have 
assessed perceived chronic or semi-acute stress (both assessing stress over weeks to months) 
using multiple variables 
91-93
 and recently some studies have used a visual analogue scale to 
measure the effect of a stress test 
94 95
. These latter studies are regrettably not directly 
comparable to the results of this thesis although they give us an indication that a visual analogue 
scale is at least as discriminating as a questionnaire when it comes to highlighting differences in 
stress levels between two groups. However, a self-estimated acute stress scale could be the 
subject of further studies that could deepen our understanding of the level of acute stress 
experienced by TSC patients. 
 
Mental stress and stress hormones in Takotsubo stress cardiomyopathy 
In Study III we found no difference between TSC patients and controls with regards to 
salivary cortisol. Furthermore, the TSC patients experienced lower self-estimated acute stress 
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compared to controls during mental stress. However, in a recent study by Smeijers et al. they 
found that TSC was associated with higher norepinephrine and dopamine levels during mental 
stress (anger recall interview and mental arithmetics) 
170
. TSC patients also had lower 
emotional arousal compared to controls while no evidence was found for dysregulated cortisol 
response. This study confirms our findings from Study III that TSC patients have a lower 
emotional arousal and normal cortisol response compared to controls while introducing the 
hypothesis that catecholamine hyper-reactivity and not emotional hyper-reactivity to stress is 
likely to play a role in myocardial vulnerability in TSC. 
 
 
STRENGTHS AND LIMITATIONS 
 
One strength of Study I is that 64% of eligible MINCA patients in the Stockholm Metropolitan 
Area were included in the study. In other studies using CMR on MINCA only a selected patient 
clientele were included or we have no data as to the extent to which these studies covered the 
MINCA population during the inclusion period 
73-76
. One strength of Studies II-IV is the 
selection of both TSC patients and controls. The TSC patients were investigated with CMR 
prior to inclusion in these studies, thus minimizing the amount of patients whereas in reality a 
TSC diagnosis could be something different. Another strength of Studies II-IV is the selection 
of the controls. The controls were sex- and age-matched volunteers recruited from the general 
population often born on the same day as the TSC patients, thereby ensuring a good match, not 
just in sex, but also age. 
 
One limitation of Study I is that we only included patients between 35 and 70 years of age. The 
reason for this was that we wanted only to include patients who had a clear indication for 
coronary angiography. However, we know from previous studies that a significant proportion of 
TSC patients are older than 70 years of age 
155
. Accordingly, it seems reasonable to perform 
CMR even on patients older than 70 years of age. One limitation of Studies II-IV was the small 
sample size. Whether larger sample groups could have been able to show differences in DTI, 
HRV, SC or CFR between the groups remains to be determined. A second limitation was the 
accuracy of measuring CFR during high-dose dobutamine stress. A relatively high intra- and 
inter-observer variability during high-dose dobutamine limited our ability to accurately assess 
CFR. A possible difference in CFR at high-dose dobutamine remains to be proven. Thirdly, in 
this study we chose to use dobutamine instead of adrenaline, for example, for ethical and 
safety reasons. One possible explanation for the lack of significant results at high-dose 
dobutamine stress is the fact that dobutamine only has a weak beta2 effect. In animal studies the 
negative inotropic effect at high catecholamine doses in a TSC event is mediated via the beta2-
receptors 
55 57
. Therefore, dobutamine, despite being a catecholamine and reports of cases in 
which it has precipitated a TSC event 
147 148
, could possibly be inadequate to precipitate 
microvascular dysfunction even at high doses.  
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FUTURE STUDIES 
 
In order to more accurately diagnose different types of MINCA, CMR should be performed at 
an early stage. If CMR were performed on day 2-4 after admission to hospital, it would be 
possible to asses not only LGE and wall-motion abnormalities but also the extent of oedema 
could (using CMR with T1- or T2-weighted protocols) 
79 143
. This would give us the opportunity 
to make the diagnosis TSC not only from absence of LGE and presence of reversible left- or 
right- ventricular dysfunction but also by directly assessing the circumferential oedema typical 
of TSC. By using early CMR the percentage of patients with a reliable diagnosis would 
probably increase from the current half, approximately, of all MINCA patients, to 70% or more. 
 
Up to now the Mayo Clinic criteria for TSC have often been used 
29
. These criteria have been 
questioned, however, mostly because of new evidence supporting non-typical forms of TSC 
30
. 
However, the diagnosis of TSC could be improved by using CMR criteria. Possible diagnostic 
criteria could include: the presence of transient myocardial oedema and/or wall-motion 
abnormalities with circumferential distribution, the absence of LGE corresponding to 
circumferential oedema and/or wall-motion abnormalities and the absence of coronary artery 
occlusion or stenosis, corresponding to circumferential oedema and/or wall-motion 
abnormalities. Similar CMR criteria were proposed by Eitel et al. in 2011, as follows: (1) severe 
LV dysfunction in a non-coronary regional distribution pattern; (2) myocardial oedema in the 
same location as the regional wall-motion abnormality; (3) the absence of high signal areas in 
LGE images (a cut-off value of >5 standard deviations should be used to define significance); 
(4) increased early myocardial gadolinium uptake. The diagnosis is confirmed if after >4 weeks 
all diagnostic have been completely or almost completely resolved. 
 
By using CMR as diagnostic criteria one could reveal cases of TSC precipitated by myocarditis 
or obstructive coronary artery disease, as has been noted by several researchers 
171 172
. Hence, 
the stunning (or parts of it) seen in ACS could in reality be TSC precipitated by the pain and 
stress experienced during an ACS and not by ischemia. Furthermore, diagnostic criteria may 
even include incomplete circumferential oedema or wall-motion abnormalities in which only 
parts of the myocardium are affected and there is no corresponding LGE or coronary artery 
disease. However, in cases of small oedema or wall-motion abnormalities reliable diagnostic 
criteria for both TSC and myocarditis probably remain difficult to establish. In such cases, a 
second CMR two months or more after the acute event could be helpful. A second CMR could 
potentially more clearly visualize LGE compared to a CMR performed in the sub-acute phase 
and denote the regression of myocardial oedema over time. A second CMR in combination with 
echocardiography, clinical findings and laboratory chemistry analysis could thus improve the 
number of MINCA patients with a reliable diagnosis even in the most diagnostically 
challenging patients. 
 
Evidence for guidelines regarding treatment strategies for MINCA patients as well as TSC 
patients is still lacking. However, a few retrospective and non-randomized studies have been 
performed. Palla et al. noticed that pre-treatment with beta-blockers did not affect the severity 
of a TSC episode and Sharkey et al. found that beta-blockers were not absolutely protective 
against the development of a TSC event 
40 173
. In a recent systematic review Singh et al. found 
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an annual recurrence rate of 1.5% in TSC. In the same study the recurrence rate was 
independent of clinic utilization of beta-blockers prescription, but inversely correlated with 
ACE-inhibitor and angiotensin-receptor blocker prescription 
146
. However, prospective and 
randomized studies are needed in this field. One option for performing randomized studies 
could be to use the SWEDEHEART registry, which provides the opportunity to perform a 
prospective randomized registry clinical trial (R-RCT) 
174
. One attractive study might be to 
evaluate the effect of beta-blocker treatment or no beta-blocker treatment in TSC patients. The 
SWEDEHEART registry, with its relatively large population, also has the benefit of a large 
amount of patient data included in the registry.  
 
 
CLINICAL IMPLICATIONS 
 
The clinical implication from Study I is that CMR increases the proportion of MINCA patients 
who receive a reliable diagnosis. According to our calculations approximately 50% of MINCA 
patients receive a reliable diagnosis after CMR and more than half of MINCA patients receive a 
different diagnosis after CMR compared to what they have upon their discharge from the 
hospital. From Studies II and III we have learned that vulnerability to catecholamine and mental 
stress does not persist in TSC patients. Recurrence of TSC is possible but relatively rare, and 
Studies II and III strengthen this hypothesis. Furthermore, after the recovery of systolic function 
there seems to be a mild myocardial dysfunction with slow regression and normalization after 
more than a year. If those of us in clinical practice acknowledge the fact that TSC patients have 
a slow recovery of ventricular function, our TSC patients will experience a much greater 
understanding of their disease and their situation. 
 
 
CONCLUSIONS 
 
From the studies in this thesis we can draw the following conclusions: 
 
1. MINCA is more common than previously shown and is associated with a normal CMR. 
TSC constitutes a substantial part of MINCA.  
2. Vulnerability to catecholamine stress, measured by sensitive MPI, does not persist in 
TSC patients. 
3. Mental stress does not induce a pathological response in TSC patients measured by DTI, 
HRV or salivary cortisol 28 months after the acute event. Studies II-III indicate a slow 
recovery for TSC patients measured by DTI.  
4. We could not confirm that the catecholamine dobutamine induced microvascular 
dysfunction in TSC patients. However, we found a small but significant difference in 
CFR at low-dose dobutamine which implies that the role of microvascular function in 
TSC needs to be further explored. 
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